DHD14801
Research Grade Bivatuzumab
Größe
£200.00
- SKU:
- DHD14801
- Zusätzliche Namen:
- BIWA4, CAS: 214559-60-1
- Physischer Zustand:
- Liquid
- Reinheit:
- >95%
- Aufreinigung:
- Protein A/G purified from cell culture supernatant.
- Lagerbedingungen:
- -20[o]C Avoid freeze/thaw cycles., 2-8[o]C Avoid freeze/thaw cycles., -70[o]C Avoid freeze/thaw cycles.
- Hersteller:
- AntibodySystems
- Host:
- Human
- Reaktivitäten:
- Human
- Buffer:
- 0.01M PBS, pH 7.4.
- Immunogen:
- Hyaluronate receptor, MDU2, HUTCH-I, MDU3, Phagocytic glycoprotein I, CDw44, Epican, Phagocytic glycoprotein 1, ECMR-III, CD44, Hermes antigen, PGP-1, PGP-I, GP90 lymphocyte homing/adhesion receptor, LHR, CD44 antigen, MIC4, Extracellular matrix receptor III, Heparan sulfate proteoglycan
- Klon:
- Bivatuzumab
- Uniprot:
- P16070
- Synonyme:
- CD44 antigen;CDW44;cell surface glycoprotein CD44;chondroitin sulfate proteoglycan 8;CSPG8;ECMR-III;epican;extracellular matrix receptor III;GP90 lymphocyte homing/adhesion receptor;HCELL;hematopoietic cell E- and L-selectin ligand;heparan sulfate proteoglycan;Hermes antigen;homing function and Indian blood group system;HUTCH-I;hyaluronate receptor;IN;Indian blood group antigen;LHR;MC56;MDU2;MDU3;MIC4;Pgp1;phagocytic glycoprotein 1;Phagocytic glycoprotein I;soluble CD44
- Versandbedingungen:
- Blue Ice